Arlington Capital Partners portfolio company AVS Bio has acquired ImmunoPrecise Antibodies Europe (IPA Europe). IPA Europe is a carve-out of ImmunoPrecise Antibodies, a biotherapeutics company ...

Arlington Capital Partners ("Arlington"), a Washington, D.C.-area private investment firm specializing in government regulated industries, today announced that its portfolio company AVS Bio, a leading ...

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) ("IPA" or the "Company"), a biotherapeutics company delivering advanced solutions ...

AI research is central to many of the deals. In April, French pharmaceutical giant Sanofi announced a $1.7 billion agreement ...

Key Points GAAP revenue of $864 million for Q2 2025 was flat year over year but exceeded analyst estimates by $9.92 million, or 1.16%. GAAP earnings per share were $0.49, matching analyst expectations ...

BP's announcement on Monday of its largest global oil and gas discovery in 25 years in Brazil's offshore Santos basin bodes ...

Britain’s BP oil and gas giant announced this week its biggest oil and gas discovery in 25 years off the coast of Brazil.

A new transnational coalition of Liberian citizens, diaspora leaders, activists, and scholars has officially launched the ...

Global entertainment and media company Warner Bros. Discovery (NASDAQ:WBD) will be announcing earnings results this Thursday ...

Smaller video streaming platforms in India face significant tech and user experience challenges, struggling with playback ...

Canaccord Genuity analyst Tim Hoff joins us for his third annual Diggers portfolio. Can he go back to back on his recent ...